Alanine- and glycine-containing therapeutic agent for hepatitis

Details Alanine- and glycine-containing therapeutic agent for hepatitis Alanine- and glycine-containing therapeutic agent for hepatitis

2007-04-24

2007-04-24

Padmanabhan, Sreeni (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

C424S225100, C514S894000

Reexamination Certificate

active

10196816

ABSTRACT:
The therapeutic agent for hepatitis, containing alanine and glycine, has only a slight toxicity and it can be administered either orally or intravenously to improve the liver function.

REFERENCES:
patent: 4085207 (1978-04-01), Aoki et al.
patent: 4491589 (1985-01-01), Dell et al.
patent: 4499076 (1985-02-01), Ohashi et al.
patent: 4698419 (1987-10-01), Chazov et al.
patent: 5580903 (1996-12-01), Mawatari et al.
patent: 6048543 (2000-04-01), Schneider et al.
patent: 26 36 828 (1978-02-01), None
patent: 5-221 858 (1993-08-01), None
patent: 6-183962 (1994-07-01), None
Pharmacotherapy, A Pathophysiologic Approach, 2nd ed. Elsevier, Dipiro et al. p. 579, figure 34.1, 1992.
M. Yin, et al., The Journal of Pharmacology and Experimental Therapeutics, vol. 286, No. 2, XP-002281490, pp. 1014-1019, “Glycine Accelerates Recovery From Alcohol-Induced Liver Injury1”, Aug. 1998.

Affiliated with

Also associated with

Rating

Alanine- and glycine-containing therapeutic agent for hepatitis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alanine- and glycine-containing therapeutic agent for hepatitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alanine- and glycine-containing therapeutic agent for hepatitis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3725463